Google DeepMind AI speeds up search for disease genes

Google's AI subsidiary, DeepMind, has harnessed artificial intelligence to identify potentially disease-causing changes in human DNA, pinpointing 89% of crucial mutations. This breakthrough promises to expedite disease diagnosis and enhance treatment research. The technique involves assessing the order of components in human DNA strands, identifying errors that can lead to diseases. Previously, only 0.1% of mutations were categorized, but DeepMind's AlphaMissense has significantly increased that figure. This innovation empowers researchers to focus on previously unidentified disease-causing regions, streamlining their efforts. The tool, tested by Genomics England and the NHS, promises to revolutionize clinical genetics and molecular biology.

‍